GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 28/09/2010
PIL Imigran Injection, Subject

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/09/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 23/05/2008 and displayed until 28/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 11/07/2007 and displayed until 23/05/2008
Reasons for adding or updating:
  • Change to how to administer the medicine
Updated on 07/06/2006 and displayed until 11/07/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to how the medicine works
  • Change to Further Information section
  • Change to date of revision
Updated on 01/11/2005 and displayed until 07/06/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 24/02/2004 and displayed until 01/11/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 06/11/2003 and displayed until 24/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 09/05/2002 and displayed until 06/11/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 24/09/2001 and displayed until 09/05/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 02/02/2001 and displayed until 24/09/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/12/2000 and displayed until 02/02/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   sumatriptan succinate